newsfilter
← Latest News
GlobeNewswire·

Impel NeuroPharma Announces Third Quarter 2021 Financial Results and Provides Corporate Update

Launched Trudhesa™ (dihydroergotamine mesylate) Nasal Spray (0.725 mg per spray) for the Acute Treatment of Migraine with and without Aura in Adults Mobilized 60-Person Salesforce with a Targeted Focus on High-Prescribing Neurologists, Headache Spec